Division of Cardiothoracic Surgery, Baylor College of Medicine, Houston, Tex; Department of Cardiovascular Surgery, Texas Heart Institute, Houston, Tex; CHI St Luke's Health-Baylor St Luke's Medical Center, Houston, Tex; Cardiovascular Research Institute, Baylor College of Medicine, Houston, Tex.
Division of Cardiothoracic Surgery, Baylor College of Medicine, Houston, Tex; Department of Cardiovascular Surgery, Texas Heart Institute, Houston, Tex; Surgical Research Core, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex.
J Thorac Cardiovasc Surg. 2018 Dec;156(6):2053-2064.e1. doi: 10.1016/j.jtcvs.2018.05.101. Epub 2018 Jun 19.
To determine whether preoperative chronic kidney disease (CKD) is predictive of poor outcomes in patients who undergo Crawford extent II thoracoabdominal aortic aneurysm (TAAA) repair.
Data were collected from patients with CKD (defined as a preoperative estimated glomerular filtration rate <60 mL/min/1.73 m; n = 399) and without CKD (n = 604) who underwent extent II TAAA repair during 1991 to 2016. We used univariate, multivariable, and propensity score matching analyses to compare outcomes between these 2 groups.
Compared with patients without CKD, patients who presented with CKD were older and had greater rates of comorbidities, including coronary artery disease, cerebrovascular disease, and peripheral vascular disease. Patients with CKD had higher rates of operative mortality and adverse events. After propensity analysis, patients with CKD had greater rates of adverse event and renal failure necessitating dialysis, but had comparable rates of operative death to patients without CKD. Multivariable modeling indicated that CKD independently predicted adverse event (relative risk ratio [RRR] = 1.61; P = .01) and renal failure (RRR = 1.86; P = .02) after repair. After adjustment for median age, patients with CKD had substantially worse mid-term survival than those without (23.9 ± 2.4% vs 48.5 ± 2.5% at 10 years; P < .001).
In patients who present with CKD, extent II open TAAA repair carries considerable risks of operative death and adverse events. Further investigation is needed to improve renal protection during such repair.
确定术前慢性肾脏病(CKD)是否可预测行 Crawford Ⅱ型胸腹主动脉瘤(TAAA)修复术患者的不良结局。
本研究收集了 1991 年至 2016 年间行 Crawford Ⅱ型 TAAA 修复术的 CKD(术前估算肾小球滤过率<60ml/min/1.73m2;n=399)和非 CKD 患者(n=604)的数据。采用单变量、多变量和倾向评分匹配分析比较两组患者的结局。
与非 CKD 患者相比,CKD 患者年龄较大,合并症(包括冠状动脉疾病、脑血管疾病和外周血管疾病)发生率较高。CKD 患者的手术死亡率和不良事件发生率较高。经倾向评分分析后,CKD 患者的不良事件和需要透析的肾衰竭发生率较高,但手术死亡率与非 CKD 患者相当。多变量模型表明,CKD 独立预测术后不良事件(相对风险比 [RRR]1.61;P=0.01)和肾衰竭(RRR 1.86;P=0.02)。校正中位年龄后,CKD 患者的中期生存率明显低于非 CKD 患者(10 年时分别为 23.9%±2.4%和 48.5%±2.5%;P<0.001)。
对于患有 CKD 的患者,Crawford Ⅱ型开放 TAAA 修复术的手术死亡率和不良事件风险较高。需要进一步研究以改善此类修复术期间的肾脏保护。